(Aryloxy)alkyl alicyclic amines as 5-HT7 receptor inverse agonists and their use

PL452052A1Pending Publication Date: 2026-11-16JAGIELLONIAN UNIVERSITY +2
0 Cites 0 Cited by

Patent Information

Application Number
PL2025452052
Authority / Receiving Office
PL · PL
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-15
Publication Date
2026-11-16
Patent Text Reader

Abstract

The application discloses (aryloxy)alkyl derivatives of alicyclic amines defined by general formula (I) as compounds having the characteristics of selective and metabolically stable 5-HT7 receptor inverse agonists. The application also relates to the use of these compounds or pharmaceutically acceptable salts thereof for the preparation of a medicament for the treatment of disorders such as depression, anxiety disorders, panic disorder, obsessive-compulsive disorder, attention deficit hyperactivity disorder, autism spectrum disorder, schizophrenia, the treatment of diseases associated with neurodegeneration, pain, irritable bowel syndrome, and pharmaceutical compositions containing these compounds.
Need to check novelty before this filing date? Find Prior Art